[Pneumocystis carinii pneumonia].

Area of Science:

• Pediatric Infectious Diseases
• Mycology
• Immunology

Background:

• Pneumocystis pneumonia (PCP) is a significant pediatric concern, rising due to advances in pediatric reanimation and increased use of immunosuppressive therapies.
• HIV infection (acquired immunodeficiency syndrome) also contributes to the growing incidence of PCP in both children and adults.
• Pneumocystis carinii (PC), now identified as a fungus through molecular genetic studies, is the causative agent.

Purpose of the Study:

• To comprehensively review the epidemiology, pathogenesis, pathology, clinical presentation, diagnosis, and management of Pneumocystis pneumonia (PCP) in pediatric patients.
• To highlight the risk factors associated with PCP, including young age, malnutrition, prematurity, chronic debilitating diseases, and iatrogenic immunosuppression.
• To discuss diagnostic modalities and therapeutic strategies for PCP.

Main Methods:

• Review of epidemiological data, pathogen characteristics, and pathological findings of PCP.
• Analysis of clinical manifestations, including common and hypoergic forms in immunocompromised hosts.
• Evaluation of diagnostic tools such as radiological examination, pulmonary scintigraphy, laboratory tests, and seroimmunological techniques.

Main Results:

• PCP presents with characteristic macroscopic (non-aerated lung) and microscopic (alveolo-interstitial pneumonia) features.
• Diagnosis is aided by clinical presentation, radiological findings, detection of parasitic cysts in secretions, and response to therapy.
• Risk factors include biological handicaps, immunosuppression, and HIV infection.

Conclusions:

• PCP is a growing concern in vulnerable pediatric populations, necessitating prompt diagnosis and management.
• Advances in diagnostic techniques, particularly seroimmunology, offer promise for future improvements.
• Effective treatment schemes, prophylaxis, and understanding of prognosis are essential for patient outcomes.